Activation of PERK kinase in neural cells by proteasome inhibitor treatment

Journal of Neurochemistry

Volumn 112, Issue 1, 2010, Pages 238-245

  Zhang, Le ^a   Ebenezer, Philip J ^a   Dasuri, Kalavathi ^a   Bruce Keller, Annadora J ^a   Fernandez Kim, Sun Ok ^a   Liu, Ying ^a   Keller, Jeffrey N ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Aging; Neurotoxicity; P38 kinase; Proteolysis; Ubiquitin

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BETA ACTIN; BORTEZOMIB; MG 115; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN KINASE; PROTEIN PERK; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HOMEOSTASIS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; RIBOSOME; UBIQUITINATION; UPREGULATION;

ANIMALS; CELLS, CULTURED; EIF-2 KINASE; ENZYME ACTIVATION; LEUPEPTINS; NEURONS; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 71649104120     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06448.x     Document Type: Article

References (67)

1. Adams J. Kauffman M. (2004) Development of the proteasome inhibitor Velcade (Bortezomib). Cancer Invest. 22, 304 311.
2. Chain D. G., Schwartz J. H. Hegde A. N. (1999) Ubiquitin-mediated proteolysis in learning and memory. Mol. Neurobiol. 20, 125 142.
3. Chondrogianni N., Stratford F. L., Trougakos I. P., Friguet B., Rivett A. J. Gonos E. S. (2003) Central role of the proteasome in senescence and survival of human fibroblasts: induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation. J. Biol. Chem. 278, 28026 28037.
4. Chondrogianni N., Tzavelas C., Pemberton A. J., Nezis I. P., Rivett A. J. Gonos E. S. (2005) Overexpression of proteasome beta5 assembled subunit increases the amount of proteasome and confers ameliorated response to oxidative stress and higher survival rates. J. Biol. Chem. 280, 11840 11850.
5. Dietrich P., Rideout H. J., Wang Q. Stefanis L. (2003) Lack of p53 delays apoptosis, but increases ubiquitinated inclusions, in proteasomal inhibitor-treated cultured cortical neurons. Mol. Cell. Neurosci. 24, 430 441.
6. Ding Q. Keller J. N. (2003) Does proteasome inhibition play a role in mediating neuropathology and neuron death in Alzheimer's disease? J. Alzheimers Dis. 5, 241 245.
7. Ding Q., Dimayuga E. Keller J. N. (2006a) Proteasome regulation of oxidative stress in aging and age-related diseases of the CNS. Antioxid. Redox Signal. 8, 163 172.
8. Ding Q., Dimayuga E., Markesbery W. R. Keller J. N. (2006b) Proteasome inhibition induces reversible impairments in protein synthesis. FASEB J. 20, 1055 1063.
9. Ding Q., Cecarini V. Keller J. N. (2007) Interplay between protein synthesis and degradation in the CNS: physiological and pathological implications. Trends Neurosci. 30, 31 36.
10. Fragoso G., Haines J. D., Roberston J., Pedraza L., Mushynski W. E. Almazan G. (2007) p38 mitogen-activated protein kinase is required for central nervous system myelination. Glia 55, 1531 1541.
11. Fribley A., Zeng Q. Wang C. Y. (2004) Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells. Mol. Cell. Biol. 24, 9695 9704.
12. Goldberg A. L. (2003) Protein degradation and protection against misfolded or damaged proteins. Nature 426, 895 899.
13. Haines J. D., Fragoso G., Hossain S., Mushynski W. E. Almazan G. (2007) p38 Mitogen-activated protein kinase regulates myelination. J. Mol. Neurosci. 35, 23 33.
14. Halliwell B. (2002) Hypothesis: proteasomal dysfunction a primary event in neurodegeneration that leads to nitrative and oxidative stress and subsequent neuron death. Ann. N Y Acad. Sci. 962, 182 194.
15. Hamanaka R. B., Bennett B. S., Cullinan S. B. Diehl J. A. (2005) PERK and GCN2 contribute to eIF2alpha phosphorylation and cell cycle arrest after activation of the unfolded protein response pathway. Mol. Biol. Cell 16, 5493 5501.
16. Han J. Sun P. (2007) The pathways to tumor suppression via route p38. Trends Biochem. Sci. 32, 364 371.
17. Harding H. P., Novoa I., Zhang Y., Zeng H., Wek R., Schapira M. Ron D. (2000a) Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell 6, 1099 1108.
18. Harding H. P., Zhang Y., Bertolotti A., Zeng H. Ron D. (2000b) Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol. Cell 5, 897 904.
19. Harding H. P., Novoa I., Bertolotti A., Zeng H., Zhang Y., Urano F., Jousse C. Ron D. (2001) Translational regulation in the cellular response to biosynthetic load on the endoplasmic reticulum. Cold Spring Harb. Symp. Quant. Biol. 66, 499 508.
20. Hol E. M., Fischer D. F., Ovaa H. Scheper W. (2006) Ubiquitin proteasome system as a pharmacological target in neurodegeneration. Expert Rev. Neurother. 6, 1337 1347.
21. Hoozemans J. J., Veerhuis R., Van Haastert E. S., Rozemuller J. M., Baas F., Eikelenboom P. Scheper W. (2005) The unfolded protein response is activated in Alzheimer's disease. Acta Neuropathol. 110, 165 172. (Pubitemid 41245205)
22. Hoozemans J. J., van Haastert E. S., Nijholt D. A., Rozemuller A. J., Eikelenboom P. Scheper W. (2009) The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus. Am. J. Pathol. 174, 1241 1251.
23. Hui L., Bakiri L., Stepniak E. Wagner E. F. (2007) p38alpha: a suppressor of cell proliferation and tumorigenesis. Cell Cycle 6, 2429 2433.
24. Hussain S. G. Ramaiah K. V. (2007) Reduced eIF2alpha phosphorylation and increased proapoptotic proteins in aging. Biochem. Biophys. Res. Commun. 355, 365 370.
25. Hyun D. H., Lee M., Halliwell B. Jenner P. (2003) Proteasomal inhibition causes the formation of protein aggregates containing a wide range of proteins, including nitrated proteins. J. Neurochem. 86, 363 367.
26. Keller J. N., Kindy M. S., Holtsberg F. W., St Clair D. K., Yen H. C., Germeyer A., Steiner S. M., Bruce-Keller A. J., Hutchins J. B. Mattson M. P. (1998) Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 18, 687 697.
27. Keller J. N., Hanni K. B., Gabbita S. P., Friebe V., Mattson M. P. Kindy M. S. (1999a) Oxidized lipoproteins increase reactive oxygen species formation in microglia and astrocyte cell lines. Brain Res. 830, 10 15.
28. Keller J. N., Hanni K. B. Markesbery W. R. (1999b) Oxidized low-density lipoprotein induces neuronal death: implications for calcium, reactive oxygen species, and caspases. J. Neurochem. 72, 2601 2609.
29. Keller J. N., Hanni K. B. Markesbery W. R. (2000) Impaired proteasome function in Alzheimer's disease. J. Neurochem. 75, 436 439.
30. Keller J. N., Gee J. Ding Q. (2002) The proteasome in brain aging. Ageing Res. Rev. 1, 279 293.
31. Kim R., Emi M., Tanabe K. Murakami S. (2006) Role of the unfolded protein response in cell death. Apoptosis 11, 5 13. (Pubitemid 43151639)
32. Kitiphongspattana K., Mathews C. E., Leiter E. H. Gaskins H. R. (2005) Proteasome inhibition alters glucose-stimulated (pro)insulin secretion and turnover in pancreatic {beta}-cells. J. Biol. Chem. 280, 15727 15734.
33. Lam Y. W., Lamond A. I., Mann M. Andersen J. S. (2007) Analysis of nucleolar protein dynamics reveals the nuclear degradation of ribosomal proteins. Curr. Biol. 17, 749 760.
34. Li X., Du Y., Fan X., Yang D., Luo G. Le W. (2008) c-Jun N-terminal kinase mediates lactacystin-induced dopamine neuron degeneration. J. Neuropathol. Exp. Neurol. 67, 933 944.
35. Martin D. S., Lonergan P. E., Boland B., Fogarty M. P., Brady M., Horrobin D. F., Campbell V. A. Lynch M. A. (2002) Apoptotic changes in the aged brain are triggered by interleukin-1beta-induced activation of p38 and reversed by treatment with eicosapentaenoic acid. J. Biol. Chem. 277, 34239 34246.
36. McNaught K. S. (2004) Proteolytic dysfunction in neurodegenerative disorders. Int. Rev. Neurobiol. 62, 95 119.
37. Naidoo N., Ferber M., Master M., Zhu Y. Pack A. I. (2008) Aging impairs the unfolded protein response to sleep deprivation and leads to proapoptotic signaling. J. Neurosci. 28, 6539 6548.
38. Nawrocki S. T., Carew J. S., Dunner K. Jr., Boise L. H., Chiao P. J., Huang P., Abbruzzese J. L. McConkey D. J. (2005) Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells. Cancer Res. 65, 11510 11519.
39. Obeng E. A., Carlson L. M., Gutman D. M., Harrington W. J. Jr., Lee K. P. Boise L. H. (2006) Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood 107, 4907 4916.
40. Olanow C. W. McNaught K. S. (2006) Ubiquitin-proteasome system and Parkinson's disease. Mov. Disord. 21, 1806 1823.
41. Oyadomari S. Mori M. (2004) Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 11, 381 389.
42. Paschen W. (2004) Endoplasmic reticulum dysfunction in brain pathology: critical role of protein synthesis. Curr. Neurovasc. Res. 1, 173 181.
43. Paz Gavilán M., Vela J., Castaño A., Ramos B., del Río J. C., Vitorica J. Ruano D. (2006) Cellular environment facilitates protein accumulation in aged rat hippocampus. Neurobiol. Aging 27, 973 982.
44. Pyrko P., Kardosh A., Wang W., Xiong W., Schönthal A. H. Chen T. C. (2007) HIV-1 protease inhibitors nelfinavir and atazanavir induce malignant glioma death by triggering endoplasmic reticulum stress. Cancer Res. 67, 10920 10928.
45. Raven J. F. Koromilas A. E. (2008) PERK and PKR: old kinases learn new tricks. Cell Cycle 7, 1146 1150.
46. Rideout H. J., Larsen K. E., Sulzer D. Stefanis L. (2001) Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells. J. Neurochem. 78, 899 908.
47. Rideout H. J., Wang Q., Park D. S. Stefanis L. (2003) Cyclin-dependent kinase activity is required for apoptotic death but not inclusion formation in cortical neurons after proteasomal inhibition. J. Neurosci. 23, 1237 1245.
48. Ryu E. J., Harding H. P., Angelastro J. M., Vitolo O. V., Ron D. Greene L. A. (2002) Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J. Neurosci. 22, 10690 10698.
49. Schröder M. Kaufman R. J. (2006) Divergent roles of IRE1alpha and PERK in the unfolded protein response. Curr. Mol. Med. 6, 35 36.
50. Segref A. Hoppe T. (2009) Think locally: control of ubiquitin-dependent protein degradation in neurons. EMBO Rep. 10, 44 50.
51. Seo H., Sonntag K. C. Isacson O. (2004) Generalized brain and skin proteasome inhibition in Huntington's disease. Ann. Neurol. 56, 319 328.
52. Shringarpure R. Davies K. J. (2002) Protein turnover by the proteasome in aging and disease. Free Radic. Biol. Med. 32, 84 88.
53. Shringarpure R., Catley L., Bhole D. et al. (2006) Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib. Br. J. Haematol. 134, 145 156.
54. Sugiura H., Tanaka H., Yasuda S., Takemiya T. Yamagata K. (2009) Transducing neuronal activity into dendritic spine morphology: new roles for p38 MAP kinase and N-cadherin. Neuroscientist 15, 90 104.
55. Suh Y. (2001) Age-specific changes in expression, activity, and activation of the c-Jun NH(2)-terminal kinase and p38 mitogen-activated protein kinases by methyl methanesulfonate in rats. Mech. Ageing Dev. 122, 1797 1811.
56. Sullivan P. G., Dragicevic N. B., Deng J. H., Bai Y., Dimayuga E., Ding Q., Chen Q., Bruce-Keller A. J. Keller J. N. (2004) Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover. J. Biol. Chem. 279, 20699 20707.
57. Szokalska A., Makowski M., Nowis D. et al. (2009) Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response. Cancer Res. 69, 4235 4243.
58. Thomas G. M. Huganir R. L. (2004) MAPK cascade signalling and synaptic plasticity. Nat. Rev. Neurosci. 5, 173 183.
59. Thornton T. M. Rincon M. (2008) Non-classical p38 map kinase functions: cell cycle checkpoints and survival. Int. J. Biol. Sci. 5, 44 51.
60. Unterberger U., Höftberger R., Gelpi E., Flicker H., Budka H. Voigtländer T. (2006) Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo. J. Neuropathol. Exp. Neurol. 65, 348 357.
61. Vinitsky A., Michaud C., Powers J. C. Orlowski M. (1992) Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex. Biochemistry 31, 9421 9428.
62. Wang H. Q. Takahashi R. (2007) Expanding insights on the involvement of endoplasmic reticulum stress in Parkinson's disease. Antioxid. Redox Signal. 9, 553 561.
63. Yew E. H., Cheung N. S., Choy M. S. et al. (2005) Proteasome inhibition by lactacystin in primary neuronal cells induces both potentially neuroprotective and pro-apoptotic transcriptional responses: a microarray analysis. J. Neurochem. 94, 943 956.
64. Zhang L., Ebenezer P. J., Dasuri K., Bruce-Keller A. J., Liu Y. Keller J. N. (2009) Proteasome inhibition modulates kinase activation in neural cells: Relevance to ubiquitination, ribosomes, and survival. J. Neurosci. Res. 87, 3231 3238.
65. Zhou D., Palam L. R., Jiang L., Narasimhan J., Staschke K. A. Wek R. C. (2008) Phosphorylation of eIF2 directs ATF5 translational control in response to diverse stress conditions. J. Biol. Chem. 283, 7064 7073.
66. Zhu X., Lee H. G., Raina A. K., Perry G. Smith M. A. (2002) The role of mitogen-activated protein kinase pathways in Alzheimer's disease. Neurosignals 11, 270 281.
67. Zhu X., Mei M., Lee H. G., Wang Y., Han J., Perry G. Smith M. A. (2005) P38 activation mediates amyloid-beta cytotoxicity. Neurochem. Res. 30, 791 796.